Targets and Cell Types in Immuno-Oncology Europe 2023

With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells.global.co.uk

Topics: TILs, suppressor & myeloid cells, preclinical tumour models, bispecific antibodies